Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.

Eosinophilic bronchitis is a common cause of chronic cough, characterized by sputum eosinophilia similar to that seen in asthma, but unlike asthma the patients have no objective evidence of variable airflow obstruction or airway hyperresponsiveness. The reason for the different functional associatio...

Полное описание

Библиографические подробности
Главные авторы:	Brightling, C, Ward, R, Wardlaw, A, Pavord, I
Формат:	Journal article
Язык:	English
Опубликовано:	2000

Схожие документы

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
по: Brightling, C, и др.
Опубликовано: (2003)

Eosinophilic bronchitis is an important cause of chronic cough.
по: Brightling, C, и др.
Опубликовано: (1999)

The significance of eosinophilic airway inflammation in asthma
по: Pavord, I, и др.
Опубликовано: (2002)

Eosinophilic bronchitis: an important cause of prolonged cough.
по: Brightling, C, и др.
Опубликовано: (2000)

Eosinophils in asthma and airway hyperresponsiveness.
по: Brightling, C, и др.
Опубликовано: (2004)

Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
по: Kulkarni, N, и др.
Опубликовано: (2010)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
по: Berry, M, и др.
Опубликовано: (2005)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
по: Siva, R, и др.
Опубликовано: (2007)

Eosinophilic bronchitis - what is it and why is it important?
по: Brightling, C, и др.
Опубликовано: (2000)

Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma.
по: Brightling, C, и др.
Опубликовано: (1999)

Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
по: Green, R, и др.
Опубликовано: (2006)

Observational study of the natural history of eosinophilic bronchitis.
по: Berry, M, и др.
Опубликовано: (2005)

Ozone Inhalation Attenuated the Effects of Budesonide on Aspergillus fumigatus-Induced Airway Inflammation and Hyperreactivity in Mice
по: Cameron H. Flayer, и др.
Опубликовано: (2019-09-01)

Eosinophil Inflammation and Hyperresponsiveness in the Airways as Phenotypes of COPD, and Usefulness of Inhaled Glucocorticosteroids
по: Hiroaki Kume, и др.
Опубликовано: (2019-07-01)

Asthma control, airway responsiveness and airway inflammation.
по: Pavord, I
Опубликовано: (2009)

Eosinophilic bronchitis: clinical features, management and pathogenesis.
по: Birring, S, и др.
Опубликовано: (2003)

New insights into the relationship between airway inflammation and asthma.
по: Wardlaw, A, и др.
Опубликовано: (2002)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
по: Berry, M, и др.
Опубликовано: (2007)

Eosinophilic phenotypes of airway disease.
по: Pavord, I
Опубликовано: (2013)

Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control.
по: Barnes, N, и др.
Опубликовано: (2007)

Eosinophils in Asthma and Airway Hyperresponsiveness [3] (multiple letters)
по: Brightling, C, и др.
Опубликовано: (2004)

Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis.
по: Siddiqui, S, и др.
Опубликовано: (2007)

Chapter 11. Mast cell localization within the airway smooth muscle: Relationship to airway hyperresponsiveness and other asthma phenotypes
по: Wardlaw, A, и др.
Опубликовано: (2004)

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma.
по: Brightling, C, и др.
Опубликовано: (2000)

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma
по: Brightling, C, и др.
Опубликовано: (2000)

Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol.
по: Pavord, I, и др.
Опубликовано: (2009)

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.
по: Brightling, C, и др.
Опубликовано: (2002)

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.
по: Berry, M, и др.
Опубликовано: (2004)

Outcomes of Holmium Laser, Cryoablation, and Budesonide Inhalation for Treating Severe Central Airway Stenosis in Infants
по: Lei Zhang, и др.
Опубликовано: (2023-12-01)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
по: Shrimanker, R, и др.
Опубликовано: (2017)

Airway hyperresponsiveness is dissociated from airway wall structural remodeling.
по: Siddiqui, S, и др.
Опубликовано: (2008)

Airways Disease: Phenotyping Heterogeneity Using Measures of Airway Inflammation
по: Siddiqui Salman, и др.
Опубликовано: (2007-06-01)

Association between neutrophilic airway inflammation and airflow limitation in adults with asthma.
по: Shaw, D, и др.
Опубликовано: (2007)

Role of eosinophilic airway inflammation in models of asthma
по: José R Lapa e Silva, и др.
Опубликовано: (1997-12-01)

Increased Levels of Airway Neutrophils Reduces the Inhibitory Effects of Inhaled Glucocorticosteroids on Allergen-Induced Airway Eosinophils
по: Gail M Gauvreau, и др.
Опубликовано: (2002-01-01)

IL-13 expression by blood T cells and not eosinophils is increased in asthma compared to non-asthmatic eosinophilic bronchitis
по: Mistry Vijay, и др.
Опубликовано: (2009-07-01)

Multiple inflammatory hits and the pathogenesis of severe airway disease.
по: Pavord, I, и др.
Опубликовано: (2006)

Mast-cell infiltration of airway smooth muscle in asthma.
по: Brightling, C, и др.
Опубликовано: (2002)

The A to E of airway disease.
по: Pavord, I, и др.
Опубликовано: (2010)

Eosinophilic airway inflammation and eosinophilic chronic rhinosinusitis during nivolumab and ipilimumab
по: Hirofumi Watanabe, и др.
Опубликовано: (2020-10-01)